DOCSLIB.ORG

TWEAK-Fn14 Signaling Activates Myofibroblasts to Drive Progression

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
TWEAK-Fn14 Signaling Activates Myofibroblasts to Drive Progression BASIC RESEARCH www.jasn.org TWEAK-Fn14 Signaling Activates Myofibroblasts to Drive Progression of Fibrotic Kidney Disease † † † Ivan G. Gomez,* Allie M. Roach,* Naoki Nakagawa, Aldo Amatucci,* † ‡ ‡ Bryce G. Johnson,* Kadeshia Dunn, Mark C. Kelly, Gamze Karaca,* Timothy S. Zheng,* ‡ † Suzanne Szak,* Claire M. Peppiatt-Wildman, Linda C. Burkly,* and Jeremy S. Duffield* *Research & Development, Biogen, Cambridge, Massachusetts; †Division of Nephrology, Departments of Medicine & Pathology, and Institute of Stem Cell & Regenerative Medicine, University of Washington, Seattle, Washington; and ‡Medway School of Pharmacy, University of Kent, Chatham, Kent, United Kingdom ABSTRACT The identification of the cellular origins of myofibroblasts has led to the discovery of novel pathways that potentially drive myofibroblast perpetuation in disease. Here, we further investigated the role of innate immune signaling pathways in this process. In mice, renal injury-induced activation of pericytes, which are myofibroblast precursors attached to endothelial cells, led to upregulated expression of TNF receptor su- perfamily member 12a, also known as fibroblast growth factor-inducible 14 (Fn14), by these cells. In live rat kidney slices, administration of the Fn14 ligand, TNF-related weak inducer of apoptosis (TWEAK), promoted pericyte-dependent vasoconstriction followed by pericyte detachment from capillaries. In vitro, administra- tion of TWEAK activated and differentiated pericytes into cytokine-producing myofibroblasts, and further activated established myofibroblasts in a manner requiring canonical and noncanonical NF-kB signaling path- ways. Deficiency of Fn14 protected mouse kidneys from fibrogenesis, inflammation, and associated vascular instability after in vivo injury, and was associated with loss of NF-kB signaling. In a genetic model of sponta- neous CKD, therapeutic delivery of anti-TWEAK blocking antibodies attenuated disease progression, pre- served organ function, and increased survival. These results identify the TWEAK-Fn14 signaling pathway as an important factor in myofibroblast perpetuation, fibrogenesis, and chronic disease progression. J Am Soc Nephrol 27: ccc–ccc, 2016. doi: 10.1681/ASN.2015111227 Fibrosis is a central problem in many forms of including types VI, VIII, and XII, and other matrix chronic disease affecting internal organs including proteins including fibrillin, hyaluronan, and fibro- the liver, lung, heart, central nervous system, and nectin.2–4 Recently, genetic fate-mapping studies kidney. The deposition of pathologic fibrotic ma- have demonstrated that in virtually all organs, dis- terial between and within organ units, as well as the crete populations of resident mesenchymal cells cellular activation required for such deposition, form the cellular link between initial tissue injury have been strongly implicated in the perpetuation and excessive, pathologic matrix production by mi- and progression of chronic diseases. In the kidney, grating from their niche and depositing pathologic fibrosis manifests histologically as interstitial fibro- matrix as (myo)fibroblasts.2,5–12 In the kidney, sis, glomerulosclerosis, and arteriosclerosis.1 The numerical expansion and activation of myofibro- blasts is central to fibrosis. Although a number of Received November 13, 2015. Accepted February 16, 2016. cell types have the potential to produce and secrete Published online ahead of print. Publication date available at extracellular matrix (ECM) proteins, including ep- www.jasn.org. ithelial cells, endothelial cells, and leukocytes, it is Correspondence: Dr. Jeremy S. Duffield or Dr. Linda C. Burkly, myofibroblasts that produce the pathogenic, fibril- Biogen, Building 6, 115 Broadway, Cambridge, MA, 02142. lar collagenous matrix in vivo, especially collagen Email: jeremy.duffi[email protected] or [email protected] types I, III, V, VII, and XI, microfibril collagens Copyright © 2016 by the American Society of Nephrology J Am Soc Nephrol 27: ccc–ccc, 2016 ISSN : 1046-6673/2711-ccc 1 BASIC RESEARCH www.jasn.org many of these mesenchymal cells are closely associated with Furthermore, release of TWEAK by increased blood flow capillaries, perform vascular functions, have mesenchymal in the kidney may be an early feature of the development stem cell characteristics, and may be referred to as pericytes of kidney disease.34 Since such microvascular problems are or perivascular cells.1,3,9,13,14 In the mouse kidney, many of recognized to drive kidney disease,14 and since pericytes are these perivascular cells lack expression of NG2 but express directly implicated in the fibrogenic process, we hypothe- PDGFRb, whereas in rat and human kidneys the expression sized that Fn14 may contribute to fibrogenesis by regulating of NG2 is more variable.15–17 pericyte functions directly. Here, we evaluate the role of The activation of pericytes results in migration from the Fn14 in the activation of kidney myofibroblast precursors, capillary to the interstitial space. This detachment from the as well as in the persistence of established myofibroblasts, capillary is associated with vascular instability, which may and determined its contribution to renal fibrogenesis and result in pathologic angiogenesis or capillary loss.3,13,18 Studies end organ failure. suggest that vascular instability and pericyte activation are di- rectly linked due the loss of survival signals, quiescence sig- nals, and basement membrane maintenance. Failure to resolve RESULTS these responses, either as a result of repetitive injury or loss of normal restorative mechanisms, appears to be central to the Fn14 is Expressed by Pericytes and Myofibroblasts in progression to chronic disease. the Kidney Although several secreted factors that contribute to cellular Tnfrsf12 (Fn14) and Tnfsf12 (TWEAK) were highly upregu- crosstalk and perpetuation of the fibrotic response have been lated in the setting of kidney injury with fibrosis caused by identified, including TGFb,VEGF,CTGF,WNTligands, surgical unilateral ureteral obstruction (UUO) (Figure 1, A Hedgehog ligands, and PDGFs, additional factors likely play and B). Flow cytometry-sorted pericytes from normal kid- critical roles in fibrogenesis. In particular, myofibroblasts neys, and activated pericytes (which progressively differentiate show activation of innate immune signaling pathways, sug- into myofibroblasts) sorted from diseased kidneys were eval- gesting that additional cytokine/receptor interactions contrib- uated for expression of Tnfrsf12 by quantitative PCR (qPCR). ute to their appearance and maintenance in a pathologic Tnfrsf12 was present in healthy pericytes and expression pro- state.3,4,11,19,20 gressively increased with disease (Figure 1B). In keeping with TNFreceptor and TNF superfamily receptor–signaling have high expression of Fn14 by myofibroblasts, kidney tissue been identified as potentially contributing to the pathogenesis sections from the UUO model were stained with anti-Fn14 of kidney diseases, including diabetic nephropathy, IgA ne- antibodies and costained with markers for myofibroblasts. phropathy, and lupus nephritis.21–25 TNF-related weak in- Fn14 was detected at high levels in interstitial myofibro- ducer of apoptosis (TWEAK) and its receptor fibroblast blasts, but was also detected in endothelial cells (Figure growth factor-inducible 14 (Fn14) are TNF superfamily 1C). A minority of injured epithelial cells also expressed a (TNFSF) members and have been implicated in models of low level of Fn14. Notably, only a subpopulation of myofi- kidney injury and disease, including models featuring renal broblasts appeared to express Fn14 and these were in the fibrosis, particularly where autoimmunity is thought to drive areas of greatest myofibroblast accumulation. Fn14 staining the pathogenesis. Such links with autoimmunity may derive in kidneys lacking Fn14 did not detect any specificsignal, from reports that TWEAK overexpression in vivo leads to the highlighting the specificity of this method for detecting pro- development of autoimmunity. However, the receptor and tein expression (Figure 1C, Supplemental Figure 1). A sim- ligand are upregulated in human chronic fibrosing diseases ilar pattern of staining was detected in biopsies from human of the kidney, such as FSGS and diabetic nephropathy, where CKD, where the majority of staining was detected in the there is no autoimmunity26,27; yet a role for this receptor and interstitium in myofibroblasts and endothelium (Supple- ligand directly in fibrogenesis remains undetermined.28–30 mental Figure 2). Fn14 expression was not detected in hu- Fn14 signaling via TNF receptor-associated factors has been man glomeruli. Further validation of these observations was reported to stabilize NF-kB–inducing kinase (NIK), thereby made in primary cultures of mouse kidney cells. Pericytes activating the P52/RelB NF-kB complex and causing down- expressed Fn14, seen as a single band by Western blotting. stream activation of NF-kB target genes, which have been Myofibroblasts, purified from chronically diseased and fi- suggested to be important factors in human kidney dis- brotic kidneys, expressed the receptor at significantly higher ease.31 Recently, we identified Fn14 (TNFRSF12)asanupre- levels. Epithelial and endothelial cells weakly expressed the gulated receptor on activated fibroblasts precursors, known receptor in vitro. Cultured macrophages did not express the as pericytes, and their pathologic counterparts in diseased receptor (Figure 1D). A similar pattern of expression was kidney, known as myofibroblasts. Transcripts
Load more

Recommended publications
  • Proteolytic Activation Defines Distinct Lymphangiogenic Mechanisms for VEGFC and VEGFD
    Proteolytic activation defines distinct lymphangiogenic mechanisms for VEGFC and VEGFD Hung M. Bui, … , Kari Alitalo, Mark L. Kahn J Clin Invest. 2016;126(6):2167-2180. https://doi.org/10.1172/JCI83967. Research Article Vascular biology Lymphangiogenesis is supported by 2 homologous VEGFR3 ligands, VEGFC and VEGFD. VEGFC is required for lymphatic development, while VEGFD is not. VEGFC and VEGFD are proteolytically cleaved after cell secretion in vitro, and recent studies have implicated the protease a disintegrin and metalloproteinase with thrombospondin motifs 3 (ADAMTS3) and the secreted factor collagen and calcium binding EGF domains 1 (CCBE1) in this process. It is not well understood how ligand proteolysis is controlled at the molecular level or how this process regulates lymphangiogenesis, because these complex molecular interactions have been difficult to follow ex vivo and test in vivo. Here, we have developed and used biochemical and cellular tools to demonstrate that an ADAMTS3-CCBE1 complex can form independently of VEGFR3 and is required to convert VEGFC, but not VEGFD, into an active ligand. Consistent with these ex vivo findings, mouse genetic studies revealed that ADAMTS3 is required for lymphatic development in a manner that is identical to the requirement of VEGFC and CCBE1 for lymphatic development. Moreover, CCBE1 was required for in vivo lymphangiogenesis stimulated by VEGFC but not VEGFD. Together, these studies reveal that lymphangiogenesis is regulated by two distinct proteolytic mechanisms of ligand activation: one in which VEGFC activation by ADAMTS3 and CCBE1 spatially and temporally patterns developing lymphatics, and one in which VEGFD activation by a distinct […] Find the latest version: https://jci.me/83967/pdf The Journal of Clinical Investigation RESEARCH ARTICLE Proteolytic activation defines distinct lymphangiogenic mechanisms for VEGFC and VEGFD Hung M.
    [Show full text]
  • Study of the Requirement of the CCBE1 Growth Factor in the Generation of Cardiac Myocytes from Hes Cells
    Study of the requirement of the CCBE1 growth factor in the generation of cardiac myocytes from hES cells MS.c Thesis in Biomedical Science Rita Catarina Vaz Drago Study of the requirement of the CCBE1 growth factor in the generation of cardiac myocytes from hES cells MS.c Thesis in Biomedical Science Rita Catarina Vaz Drago Orientador: Professor Doutor José António Belo Co-orientador: Doutora Andreia Bernardo Faro, 2012 ii MS.c Thesis proposal in Biomedical Science Area of Developmental Biology by the Universidade do Algarve Study of the requirement of the CCBE1 growth factor in the generation of cardiac myocytes from hES cells. Dissertação para obtenção do Grau de Mestre em Ciências Biomédicas Área de Biologia do Desenvolvimento pela Universidade do Algarve Estudo da função do factor de crescimento CCBE1 na diferenciação de miócitos cardíacos a partir de células estaminais embrionárias humanas Declaro ser a autora deste trabalho, que é original e inédito. Autores e trabalhos consultados estão devidamente citados no texto e constam da listagem de referências incluída. Copyright. A Universidade do Algarve tem o direito, perpétuo e sem limites geográficos, de arquivar e publicitar este trabalho através de exemplares impressos reproduzidos em papel ou de forma digital, ou por qualquer outro meio conhecido ou que venha a ser inventado, de o divulgar através de repositórios científicos e de admitir a sua cópia e distribuição com objetivos educacionais ou de investigação, não comerciais, desde que seja dado crédito ao autor e editor. iii ACKNOWLEDGEMENTS I thank my supervisor, Prof. José Belo, for the support he provided me during this long journey and for the opportunity of working at his laboratory.
    [Show full text]
  • Mutations in CCBE1 Cause Generalized Lymph Vessel Dysplasia
    BRIEF COMMUNICATIONS Mutations in CCBE1 cause (Fig. 1a–f)8. Subsequently, subjects with lymphangiectasias in pleura, pericardium, thyroid gland and kidney and with hydrops fetalis were generalized lymph vessel dysplasia described9,10. The entity was designated lymphedema-lymphangiectasia– mental retardation or Hennekam syndrome (MIM 235510). Occurrence in humans of affected siblings, equal occurrence among sexes and frequent consanguinity indicated autosomal recessive inheritance9. 1 2 2 1 Marielle Alders , Benjamin M Hogan , Evisa Gjini , Faranak Salehi , We collected blood samples from a series of 27 subjects with Hennekam 3 4 5 Lihadh Al-Gazali , Eric A Hennekam , Eva E Holmberg , syndrome born to 22 families. None of the subjects carried mutations 1 6 7,8 Marcel M A M Mannens , Margot F Mulder , G Johan A Offerhaus , in FLT4, FOXC2 or SOX18. We performed homozygosity mapping in 5 9 10 Trine E Prescott , Eelco J Schroor , Joke B G M Verheij , three unpublished subjects (A, B and C) originating from a small isolate 2 11,14 12 Merlijn Witte , Petra J Zwijnenburg , Mikka Vikkula , in The Netherlands. Pedigree analysis had shown the parents of subject 2,15 13–15 Stefan Schulte-Merker & Raoul C Hennekam A to be consanguineous and all three subjects to be related (Fig. 1g). We reasoned that occurrence of three cases of a rare disorder in a small Lymphedema, lymphangiectasias, mental retardation and isolate suggested homozygosity for a founder mutation. Homozygosity unusual facial characteristics define the autosomal recessive mapping identified a 5.7-Mb homozygous region on chromosome 18q21 Hennekam syndrome. Homozygosity mapping identified a with identical haplotypes in the three affected individuals (Fig.
    [Show full text]
  • Prioritization of Genes Involved in Endothelial Cell Apoptosis by Their Implication in Lymphedema Using an Analysis of Associative Gene Networks with Andsystem Olga V
    Saik et al. BMC Medical Genomics 2019, 12(Suppl 2):47 https://doi.org/10.1186/s12920-019-0492-9 RESEARCH Open Access Prioritization of genes involved in endothelial cell apoptosis by their implication in lymphedema using an analysis of associative gene networks with ANDSystem Olga V. Saik1,3*, Vadim V. Nimaev2,3, Dilovarkhuja B. Usmonov3,4, Pavel S. Demenkov1,3, Timofey V. Ivanisenko1,3, Inna N. Lavrik1,5 and Vladimir A. Ivanisenko1,3 From 11th International Multiconference “Bioinformatics of Genome Regulation and Structure\Systems Biology” - BGRS\SB- 2018 Novosibirsk, Russia. 20-25 August 2018 Abstract Background: Currently, more than 150 million people worldwide suffer from lymphedema. It is a chronic progressive disease characterized by high-protein edema of various parts of the body due to defects in lymphatic drainage. Molecular-genetic mechanisms of the disease are still poorly understood. Beginning of a clinical manifestation of primary lymphedema in middle age and the development of secondary lymphedema after treatment of breast cancer can be genetically determined. Disruption of endothelial cell apoptosis can be considered as one of the factors contributing to the development of lymphedema. However, a study of the relationship between genes associated with lymphedema and genes involved in endothelial apoptosis, in the associative gene network was not previously conducted. Methods: In the current work, we used well-known methods (ToppGene and Endeavour), as well as methods previously developed by us, to prioritize genes involved in endothelial apoptosis and to find potential participants of molecular-genetic mechanisms of lymphedema among them. Original methods of prioritization took into account the overrepresented Gene Ontology biological processes, the centrality of vertices in the associative gene network, describing the interactions of endothelial apoptosis genes with genes associated with lymphedema, and the association of the analyzed genes with diseases that are comorbid to lymphedema.
    [Show full text]
  • Genetic Epidemiology of Hypertension in Populations
    GENETIC EPIDEMIOLOGY OF HYPERTENSION IN POPULATIONS: APPLICATIONS OF MODIFIED METHODS by PRIYA BHATIA SHETTY, M.S. Submitted in partial fulfillment of the requirements For the degree of Doctor of Philosophy Dissertation Adviser: Xiaofeng Zhu, Ph.D. Department of Epidemiology and Biostatistics CASE WESTERN RESERVE UNIVERSITY January, 2014 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the dissertation of Priya Bhatia Shetty, candidate for the Doctor of Philosophy degree*. Xiaofeng Zhu, PhD Robert C. Elston, PhD Jing Li, PhD Nathan Morris, PhD September 6, 2013 *We also certify that written approval has been obtained for any proprietary material contained therein. 2 Dedication This dissertation is dedicated to my husband Manju and our children Suvan, Poppy, Jujubee, and Sayali. 3 TABLE OF CONTENTS List of Tables………………………………………………………………….…………..5 List of Figures…………………………………………………………………………….6 Abstract……………………………………………………………………….…………..7 Chapter 1. Background……………………………………………………...….…………9 Chapter 2. Specific Aims………..……………………………………………………….53 Chapter 3. Variants in CXADR and F2RL1 are associated with blood pressure and obesity in African-Americans in regions identified through admixture mapping………………..60 Chapter 4. Novel variants for HDL-C, LDL-C and triglycerides identified from admixture mapping and fine-mapping analysis in families…...…………………………………….85 Chapter 5. Identification of admixture regions associated with risk of apparent treatment- resistant hypertension in African-Americans………..………………………………….117 Chapter 6. Discussion………………………………..………………………………....137 References………………………………………………………………………………142 4 List of Tables Chapter 1. Table 1. Genome-wide Association Studies of Hypertension………...……...40 Chapter 1. Table 2. Other Analysis Methods in the Genetic Analysis of Hypertension in Unrelated Subjects………………………………………………………………...……..51 Chapter 3. Table 1. Summary statistics…………………………………………...……..80 Chapter 3. Table 2. Results of gene-based multivariable regression models……..….….81 Chapter 3.
    [Show full text]
  • Mouse Ccbe1 Conditional Knockout Project (CRISPR/Cas9)
    https://www.alphaknockout.com Mouse Ccbe1 Conditional Knockout Project (CRISPR/Cas9) Objective: To create a Ccbe1 conditional knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Ccbe1 gene (NCBI Reference Sequence: NM_178793 ; Ensembl: ENSMUSG00000046318 ) is located on Mouse chromosome 18. 11 exons are identified, with the ATG start codon in exon 1 and the TAG stop codon in exon 11 (Transcript: ENSMUST00000130300). Exon 3 will be selected as conditional knockout region (cKO region). Deletion of this region should result in the loss of function of the Mouse Ccbe1 gene. To engineer the targeting vector, homologous arms and cKO region will be generated by PCR using BAC clone RP23-138G22 as template. Cas9, gRNA and targeting vector will be co-injected into fertilized eggs for cKO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Mice homozygous for a knock-out allele exhibit prenatal lethality associated with edema and absence of lymphatic vessels. Exon 3 starts from about 17.65% of the coding region. The knockout of Exon 3 will result in frameshift of the gene. The size of intron 2 for 5'-loxP site insertion: 197081 bp, and the size of intron 3 for 3'-loxP site insertion: 9125 bp. The size of effective cKO region: ~553 bp. The cKO region does not have any other known gene. Page 1 of 8 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele gRNA region 5' gRNA region 3' 1 3 11 Targeting vector Targeted allele Constitutive KO allele (After Cre recombination) Legends Exon of mouse Ccbe1 Homology arm cKO region loxP site Page 2 of 8 https://www.alphaknockout.com Overview of the Dot Plot Window size: 10 bp Forward Reverse Complement Sequence 12 Note: The sequence of homologous arms and cKO region is aligned with itself to determine if there are tandem repeats.
    [Show full text]
  • Loss of ADAMTS3 Activity Causes Hennekam Lymphangiectasia–Lymphedema Syndrome 3 Pascal Brouillard1,‡, Laura Dupont2,‡, Raphael Helaers1, Richard Coulie1, George E
    Human Molecular Genetics, 2017, Vol. 26, No. 21 4095–4104 doi: 10.1093/hmg/ddx297 Advance Access Publication Date: 2 August 2017 Original Article ORIGINAL ARTICLE Loss of ADAMTS3 activity causes Hennekam lymphangiectasia–lymphedema syndrome 3 Pascal Brouillard1,‡, Laura Dupont2,‡, Raphael Helaers1, Richard Coulie1, George E. Tiller3,†, Joseph Peeden4, Alain Colige2,‡ and Miikka Vikkula 1,5,*,‡ 1Human Molecular Genetics, de Duve Institute, University of Louvain, 1200 Brussels, Belgium, 2Laboratory of Connective Tissues Biology, University of Lie`ge, 4000 Lie`ge, Belgium, 3Pediatric Medical Genetics, Vanderbilt University Medical Center, Nashville 37232, TN, USA, 4East Tennessee Children’s Hospital, University of Tennessee Medical Center, Knoxville, TN 37916, USA and 5Walloon Excellence in Life Sciences and Biotechnology (WELBIO), de Duve Institute, University of Louvain, 1200 Brussels, Belgium *To whom correspondence should be addressed at: Human Molecular Genetics, de Duve Institute, University of Louvain, Avenue Hippocrate 74, Box B1.74.06, B-1200 Brussels, Belgium. Tel: þ32 27647496; Fax: þ32 27647460; Email: [email protected] Abstract Primary lymphedema is due to developmental and/or functional defects in the lymphatic system. It may affect any part of the body, with predominance for the lower extremities. Twenty-seven genes have already been linked to primary lymph- edema, either isolated, or as part of a syndrome. The proteins that they encode are involved in VEGFR3 receptor signaling. They account for about one third of all primary lymphedema cases, underscoring the existence of additional genetic factors. We used whole-exome sequencing to investigate the underlying cause in a non-consanguineous family with two children af- fected by lymphedema, lymphangiectasia and distinct facial features.
    [Show full text]
  • CCBE1 Mutation in Two Siblings, One Manifesting Lymphedema-Cholestasis Syndrome, and the Other, Fetal Hydrops
    CCBE1 Mutation in Two Siblings, One Manifesting Lymphedema-Cholestasis Syndrome, and the Other, Fetal Hydrops Sohela Shah1, Laura K. Conlin2, Luis Gomez3, Øystein Aagenaes4, Kristin Eiklid5, A. S. Knisely6, Michael T. Mennuti3, Randolph P. Matthews7, Nancy B. Spinner2, Laura N. Bull1,8* 1 Liver Center Laboratory, Department of Medicine, University of California San Francisco, San Francisco, California, United States of America, 2 Department of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, 3 Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, 4 Oslo University Hospital, Oslo, Norway, 5 Department of Medical Genetics, Oslo University Hospital, Ullevål, Oslo, Norway, 6 Institute of Liver Studies, King’s College Hospital, London, United Kingdom, 7 Division of Gastroenterology, Hepatology,and Nutrition, Children’s Hospital of Philadelphia and Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, 8 Institute for Human Genetics, Department of Medicine, University of California San Francisco, San Francisco, California, United States of America Abstract Background: Lymphedema-cholestasis syndrome (LCS; Aagenaes syndrome) is a rare autosomal recessive disorder, characterized by 1) neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age, and 2) severe chronic lymphedema, mainly lower limb. LCS was originally described in a Norwegian kindred in which a locus, LCS1, was mapped to a 6.6cM region on chromosome 15. Mutations in CCBE1 on chromosome 18 have been reported in some cases of lymphatic dysplasia, but not in LCS. Methods: Consanguineous parents of Mexican ancestry had a child with LCS who did not exhibit extended homozygosity in the LCS1 region.
    [Show full text]
  • Comprehensive Analysis Reveals Novel Gene Signature in Head and Neck Squamous Cell Carcinoma: Predicting Is Associated with Poor Prognosis in Patients
    5892 Original Article Comprehensive analysis reveals novel gene signature in head and neck squamous cell carcinoma: predicting is associated with poor prognosis in patients Yixin Sun1,2#, Quan Zhang1,2#, Lanlin Yao2#, Shuai Wang3, Zhiming Zhang1,2 1Department of Breast Surgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China; 2School of Medicine, Xiamen University, Xiamen, China; 3State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen, China Contributions: (I) Conception and design: Y Sun, Q Zhang; (II) Administrative support: Z Zhang; (III) Provision of study materials or patients: Y Sun, Q Zhang; (IV) Collection and assembly of data: Y Sun, L Yao; (V) Data analysis and interpretation: Y Sun, S Wang; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. #These authors contributed equally to this work. Correspondence to: Zhiming Zhang. Department of Surgery, The First Affiliated Hospital of Xiamen University, Xiamen, China. Email: [email protected]. Background: Head and neck squamous cell carcinoma (HNSC) remains an important public health problem, with classic risk factors being smoking and excessive alcohol consumption and usually has a poor prognosis. Therefore, it is important to explore the underlying mechanisms of tumorigenesis and screen the genes and pathways identified from such studies and their role in pathogenesis. The purpose of this study was to identify genes or signal pathways associated with the development of HNSC. Methods: In this study, we downloaded gene expression profiles of GSE53819 from the Gene Expression Omnibus (GEO) database, including 18 HNSC tissues and 18 normal tissues.
    [Show full text]
  • Differentially Expressed Genes in Aneurysm Tissue Compared With
    On-line Table: Differentially expressed genes in aneurysm tissue compared with those in control tissue Fold False Discovery Direction of Gene Entrez Gene Name Function Change P Value Rate (q Value) Expression AADAC Arylacetamide deacetylase Positive regulation of triglyceride 4.46 1.33E-05 2.60E-04 Up-regulated catabolic process ABCA6 ATP-binding cassette, subfamily A (ABC1), Integral component of membrane 3.79 9.15E-14 8.88E-12 Up-regulated member 6 ABCC3 ATP-binding cassette, subfamily C (CFTR/MRP), ATPase activity, coupled to 6.63 1.21E-10 7.33E-09 Up-regulated member 3 transmembrane movement of substances ABI3 ABI family, member 3 Peptidyl-tyrosine phosphorylation 6.47 2.47E-05 4.56E-04 Up-regulated ACKR1 Atypical chemokine receptor 1 (Duffy blood G-protein–coupled receptor signaling 3.80 7.95E-10 4.18E-08 Up-regulated group) pathway ACKR2 Atypical chemokine receptor 2 G-protein–coupled receptor signaling 0.42 3.29E-04 4.41E-03 Down-regulated pathway ACSM1 Acyl-CoA synthetase medium-chain family Energy derivation by oxidation of 9.87 1.70E-08 6.52E-07 Up-regulated member 1 organic compounds ACTC1 Actin, ␣, cardiac muscle 1 Negative regulation of apoptotic 0.30 7.96E-06 1.65E-04 Down-regulated process ACTG2 Actin, ␥2, smooth muscle, enteric Blood microparticle 0.29 1.61E-16 2.36E-14 Down-regulated ADAM33 ADAM domain 33 Integral component of membrane 0.23 9.74E-09 3.95E-07 Down-regulated ADAM8 ADAM domain 8 Positive regulation of tumor necrosis 4.69 2.93E-04 4.01E-03 Up-regulated factor (ligand) superfamily member 11 production ADAMTS18
    [Show full text]
  • Defective Synaptic Connectivity and Axonal Neuropathology in a Human
    Defective synaptic connectivity and axonal PNAS PLUS neuropathology in a human iPSC-based model of familial Parkinson’s disease Georgia Kouroupia, Era Taoufika, Ioannis S. Vlachosb, Konstantinos Tsiorasa, Nasia Antonioua, Florentia Papastefanakia, Dafni Chroni-Tzartoua,c, Wolfgang Wrasidlod, Delphine Bohle,1, Dimitris Stellasf, Panagiotis K. Politisg, Kostas Vekrellish, Dimitra Papadimitrioui, Leonidas Stefanish,j, Piotr Bregestovskik, Artemis G. Hatzigeorgioub, Eliezer Masliahd, and Rebecca Matsasa,2 aDepartment of Neurobiology, Hellenic Pasteur Institute, 11521 Athens, Greece; bDIANA-Lab, Hellenic Pasteur Institute, 11521 Athens, Greece; cDepartment of Neurology, Aeginition Hospital, University of Athens Medical School, 11528 Athens, Greece; dDepartment of Neurosciences, University of California, San Diego, La Jolla, CA 92093; eInstitut Pasteur, 75015 Paris, France; fDepartment of Cancer Biology, Biomedical Research Foundation of the Academy of Athens, 11527 Athens, Greece; gCenter for Basic Research, Biomedical Research Foundation of the Academy of Athens, 11527 Athens, Greece; hCenter of Clinical Research, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, 11527 Athens, Greece; iNeurology Clinic, Henry Dunant Hospital Center, 11526 Athens, Greece; jSecond Department of Neurology, University of Athens Medical School, 11527 Athens, Greece; and kAix-Marseille Université, INSERM, Institut de Neurosciences des Systèmes, 13005 Marseille, France Edited by Solomon H. Snyder, Johns Hopkins University School of Medicine, Baltimore, MD, and approved March 24, 2017 (received for review October 18, 2016) α-Synuclein (αSyn) is the major gene linked to sporadic Parkinson’s number of p.A53T-based in vitro and in vivo animal models have disease (PD), whereas the G209A (p.A53T) αSyn mutation causes a been created for understanding the mechanisms of PD patho- familial form of PD characterized by early onset and a generally genesis and progression and for assisting in drug development.
    [Show full text]
  • Collagen and Calcium-Binding EGF Domains 1 Is Frequently Inactivated in Ovarian Cancer by Aberrant Promoter Hypermethylation and Modulates Cell Migration and Survival
    British Journal of Cancer (2010) 102, 87 – 96 & 2010 Cancer Research UK All rights reserved 0007 – 0920/10 $32.00 www.bjcancer.com Collagen and calcium-binding EGF domains 1 is frequently inactivated in ovarian cancer by aberrant promoter hypermethylation and modulates cell migration and survival CA Barton1, BS Gloss1,WQu1, AL Statham1, NF Hacker1,2,3, RL Sutherland1,3, SJ Clark1,3 and PM O’Brien*,1,3 1 2 Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, Sydney, NSW 2010, Australia; Gynaecological Cancer Centre, Royal 3 Hospital for Women, Randwick, Sydney NSW 2031, Australia; Faculty of Medicine, University of NSW, Randwick, Sydney NSW 2031, Australia Clinical Studies BACKGROUND: Collagen and calcium-binding EGF domains 1 (CCBE1) is an uncharacterised gene that has down-regulated expression in breast cancer. As CCBE1 maps to 18q21.32, a region frequently exhibiting loss of heterozygosity in ovarian cancer, the aim of this study was to determine the expression and function of CCBE1 in ovarian cancer. METHODS: Expression and methylation patterns of CCBE1 were determined in ovarian cancer cell lines and primary tumours. CCBE1 contains collagen repeats and an aspartic acid/asparagine hydroxylation/EGF-like domain, suggesting a function in extracellular matrix remodelling and migration, which was determined using small-interfering RNA (siRNA)-mediated knockdown and over-expression of CCBE1 in cell lines. RESULTS: CCBE1 is expressed in normal ovary, but is reduced in ovarian cancer cell lines and primary carcinomas. Pharmacological demethylation/deacetylation in ovarian cancer cell lines re-induced CCBE1 expression, indicating that epigenetic mechanisms contribute to its silencing in cancer.
    [Show full text]